| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |